Blood Biomarkers for Alzheimer’s Disease in Down Syndrome

Epidemiological evidence suggests that by the age of 40 years, all individuals with Down syndrome (DS) have Alzheimer’s disease (AD) neuropathology. Clinical diagnosis of dementia by cognitive assessment is complex in these patients due to the pre-existing and varying intellectual disability, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Montoliu-Gaya, Laia, Strydom, Andre, Blennow, Kaj, Zetterberg, Henrik, Ashton, Nicholas James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397053/
https://www.ncbi.nlm.nih.gov/pubmed/34441934
http://dx.doi.org/10.3390/jcm10163639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397053/
https://www.ncbi.nlm.nih.gov/pubmed/34441934
http://dx.doi.org/10.3390/jcm10163639

Ejemplares similares